Louisiana State Employees Retirement System Regeneron Pharmaceuticals, Inc. Transaction History
Louisiana State Employees Retirement System
- $5.54 Billion
- Q4 2025
A detailed history of Louisiana State Employees Retirement System transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 12,000 shares of REGN stock, worth $8.32 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
12,000
Previous 12,900
6.98%
Holding current value
$8.32 Million
Previous $7.25 Million
14.74%
% of portfolio
0.15%
Previous 0.13%
Shares
26 transactions
Others Institutions Holding REGN
# of Institutions
1,501Shares Held
86.6MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...